{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T08:25:22Z","timestamp":1787214322917,"version":"build-2736575974"},"reference-count":26,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["HEALTH-F2-2009\\u2013602299 EU-CERT-ICD"],"award-info":[{"award-number":["HEALTH-F2-2009\\u2013602299 EU-CERT-ICD"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010763","name":"Zorginstituut Nederland","doi-asserted-by":"publisher","award":["837004009"],"award-info":[{"award-number":["837004009"]}],"id":[{"id":"10.13039\/501100010763","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm O2"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.hroo.2026.04.013","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T06:20:39Z","timestamp":1777011639000},"page":"1546-1554","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Refining risk stratification for primary prevention ICD therapy: Insights from cardiac MRI in the DO-IT registry"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9742-7902","authenticated-orcid":false,"given":"Marthe A.J.","family":"Becker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luuk H.G.A.","family":"Hopman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom E.","family":"Verstraelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos","family":"Perdeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Lotte C.J.","family":"van der Lingen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton E.","family":"Tuinenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas V.A.","family":"Boersma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander H.","family":"Maass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Paul H.M.","family":"Delnoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan A.J.","family":"Timmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tjeerd","family":"Germans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vokko P.","family":"van Halm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur A.M.","family":"Wilde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis P.","family":"Allaart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hroo.2026.04.013_bib1","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJM199711273372202","article-title":"A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias","volume":"337","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2026.04.013_bib2","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2026.04.013_bib3","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hroo.2026.04.013_bib4","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"Kober","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2026.04.013_bib5","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s12471-024-01859-7","article-title":"Assessment of ICD eligibility in non-ischaemic cardiomyopathy patients: a position statement by the Task Force of the Dutch Society of Cardiology","volume":"32","author":"van der Lingen","year":"2024","journal-title":"Neth Heart J"},{"key":"10.1016\/j.hroo.2026.04.013_bib6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s12471-025-01946-3","article-title":"Prognostic value of late gadolinium enhancement cardiac MRI for ICD therapy in non-ischaemic cardiomyopathy : A 5-year cohort study","volume":"33","author":"Hopman","year":"2025","journal-title":"Neth Heart J"},{"key":"10.1016\/j.hroo.2026.04.013_bib7","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018108","article-title":"Long-term outcomes among a nationwide cohort of patients using an implantable cardioverter-defibrillator: UMBRELLA study final results","volume":"10","author":"Briongos-Figuero","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hroo.2026.04.013_bib8","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1093\/eurheartj\/ehac496","article-title":"Device-related complications in subcutaneous versus transvenous ICD: a secondary analysis of the PRAETORIAN trial","volume":"43","author":"Knops","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hroo.2026.04.013_bib9","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018063","article-title":"Dutch outcome in implantable cardioverter-defibrillator therapy: implantable cardioverter-defibrillator-related complications in a contemporary primary prevention cohort","volume":"10","author":"van Barreveld","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hroo.2026.04.013_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchf.2024.09.014","article-title":"Revisiting ICD therapy for primary prevention in patients with heart failure and reduced ejection fraction","volume":"13","author":"Yehya","year":"2025","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.hroo.2026.04.013_bib11","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/CIRCIMAGING.111.971549","article-title":"Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defibrillator: evaluation of multiple scar quantification measures for late gadolinium enhancement magnetic resonance imaging","volume":"5","author":"Gao","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.hroo.2026.04.013_bib12","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1161\/CIRCULATIONAHA.116.026910","article-title":"Association between Midwall late gadolinium enhancement and sudden cardiac death in patients with dilated cardiomyopathy and mild and moderate left ventricular systolic dysfunction","volume":"135","author":"Halliday","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2026.04.013_bib13","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jacc.2010.06.062","article-title":"Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death","volume":"57","author":"Iles","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2026.04.013_bib14","article-title":"Prediction of ventricular arrhythmias and sudden cardiac death by quantification and location of late gadolinium enhancement on cardiac magnetic resonance: a systematic review and meta-analysis","volume":"27","author":"Jensen","year":"2025","journal-title":"Europace"},{"key":"10.1016\/j.hroo.2026.04.013_bib15","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s12471-017-1016-x","article-title":"Dutch outcome in implantable cardioverter-defibrillator therapy (DO-IT): registry design and baseline characteristics of a prospective observational cohort study to predict appropriate indication for implantable cardioverter-defibrillator","volume":"25","author":"van Barreveld","year":"2017","journal-title":"Neth Heart J"},{"key":"10.1016\/j.hroo.2026.04.013_bib16","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","volume":"36","author":"Priori","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hroo.2026.04.013_bib17","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jcmg.2010.11.015","article-title":"Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance","volume":"4","author":"Flett","year":"2011","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hroo.2026.04.013_bib18","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hroo.2026.04.013_bib19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(20)30748-0","article-title":"Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials","volume":"396","author":"Vaduganathan","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.hroo.2026.04.013_bib20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJMoa1609758","article-title":"Declining risk of sudden death in heart failure","volume":"377","author":"Shen","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2026.04.013_bib21","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1093\/eurheartj\/ehz773","article-title":"Time trends in sudden cardiac death risk in heart failure patients with cardiac resynchronization therapy: a systematic review","volume":"41","author":"Barra","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hroo.2026.04.013_bib22","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1016\/j.hrthm.2015.08.020","article-title":"Contemporary rates of appropriate shock therapy in patients who receive implantable device therapy in a real-world setting: from the Israeli ICD Registry","volume":"12","author":"Sabbag","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2026.04.013_bib23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.hroo.2023.01.001","article-title":"Association of late gadolinium enhancement in cardiac magnetic resonance with mortality, ventricular arrhythmias, and heart failure in patients with nonischemic cardiomyopathy: a systematic review and meta-analysis","volume":"4","author":"Al-Sadawi","year":"2023","journal-title":"Heart Rhythm O2"},{"key":"10.1016\/j.hroo.2026.04.013_bib24","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.amjcard.2019.05.026","article-title":"The benefit of prophylactic implantable cardioverter defibrillator implantation in asymptomatic heart failure patients with a reduced ejection fraction","volume":"124","author":"van der Lingen","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hroo.2026.04.013_bib25","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1056\/NEJMoa2304542","article-title":"Long-term outcomes of resynchronization-defibrillation for heart failure","volume":"390","author":"Sapp","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2026.04.013_bib26","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1093\/eurheartj\/ehaf009","article-title":"2024 Revision of the level of evidence grading system for ESC clinical practice guideline recommendations I: Therapy and prevention","volume":"46","author":"Juni","year":"2025","journal-title":"Eur Heart J"}],"container-title":["Heart Rhythm O2"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666501826001790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666501826001790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T08:09:54Z","timestamp":1787213394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666501826001790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2666501826001790"],"URL":"https:\/\/doi.org\/10.1016\/j.hroo.2026.04.013","relation":{},"ISSN":["2666-5018"],"issn-type":[{"value":"2666-5018","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Refining risk stratification for primary prevention ICD therapy: Insights from cardiac MRI in the DO-IT registry","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm O2","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hroo.2026.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Heart Rhythm Society. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}